Linear IgA/IgG bullous dermatosis reacts with multiple laminins and integrins

Eur J Dermatol. 2015 Sep-Oct;25(5):418-23. doi: 10.1684/ejd.2015.2555.

Abstract

Background: Since the original description by Zone et al in 1994, the disease entity and target antigens in linear IgA/IgG bullous dermatosis (LAGBD) have not been clarified in 20 years.

Objectives: To determine autoantibodies and autoantigens in a new LAGBD case which showed atypical clinical and histopathological findings without apparent mucosal involvement.

Materials and methods: We performed various indirect immunofluorescence and immunoblotting studies.

Results: Indirect immunofluorescence of 1M NaCl-split skin showed IgG and IgA reactivity with both epidermal and dermal sides. Immunoblotting studies using various antigen sources revealed circulating IgG and IgA antibodies reactive with laminin-332, laminin-γ1 and integrin α6β4 in various patterns. Absorption study using recombinant proteins of laminin-γ1 indicated that the patient serum reacted with different epitopes between laminin-γ1 and laminin-γ2.

Conclusions: This study presented for the first time a LAGBD patient with IgG and IgA antibodies to various laminins and integrins.

Keywords: integrin α6β4; laminin-332; laminin-γ1; linear IgA/IgG bullous dermatosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Administration, Oral
  • Administration, Topical
  • Adrenal Cortex Hormones / therapeutic use
  • Aged, 80 and over
  • Autoantibodies / blood*
  • Biopsy, Needle
  • Fluorescent Antibody Technique, Indirect
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Integrins / immunology
  • Integrins / metabolism*
  • Laminin / immunology
  • Laminin / metabolism*
  • Linear IgA Bullous Dermatosis / drug therapy
  • Linear IgA Bullous Dermatosis / immunology*
  • Linear IgA Bullous Dermatosis / pathology*
  • Male
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Autoantibodies
  • Integrins
  • Laminin